CLOUDR GROUP LIMITED Financials ClouDr Group Limited
Equities
9955
KYG2216H1011
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.43 HKD | +0.88% |
|
+11.00% | -49.93% |
| Apr. 15 | ClouDr Launches Digital Employee to Improve Online-to-Offline Operation Services | MT |
| Mar. 22 | ClouDr Group's Net Loss Shrinks 81% in 2023 as Revenue Rises 23.5% | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Capitalization 1 | 6,958 | 1,862 | 1,862 | - |
| Enterprise Value (EV) 1 | 6,728 | 3,655 | 1,509 | 1,757 |
| P/E ratio | -2.11 x | -10.4 x | -16.3 x | 47 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 2.33 x | 0.99 x | 0.39 x | 0.32 x |
| EV / Revenue | 2.25 x | 0.99 x | 0.32 x | 0.3 x |
| EV / EBITDA | -13.7 x | -15.3 x | 26 x | 7.62 x |
| EV / FCF | -8,307,146 x | - | - | - |
| FCF Yield | -0% | - | - | - |
| Price to Book | 3.76 x | 1.11 x | 1.18 x | 1.06 x |
| Nbr of stocks (in thousands) | 587,038 | 587,038 | 587,038 | - |
| Reference price 2 | 11.85 | 3.172 | 3.172 | 3.172 |
| Announcement Date | 3/22/23 | 3/21/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | - | 2,988 | 3,691 | 4,762 | 5,849 |
| EBITDA 1 | - | -489.5 | -239.4 | 57.93 | 230.6 |
| EBIT 1 | - | -591.6 | -314.2 | -26.11 | 136.5 |
| Operating Margin | - | -19.8% | -8.51% | -0.55% | 2.33% |
| Earnings before Tax (EBT) 1 | - | - | -263 | -173 | -121 |
| Net income 1 | -4,139 | -1,689 | -323.1 | -77.16 | 71.08 |
| Net margin | - | -56.52% | -8.75% | -1.62% | 1.22% |
| EPS 2 | -42.88 | -5.620 | -0.6000 | -0.1951 | 0.0675 |
| Free Cash Flow | - | -809.9 | - | - | - |
| FCF margin | - | -27.1% | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Announcement Date | 6/23/22 | 3/22/23 | 3/21/24 | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - |
| Net Cash position 1 | - | 230 | 914 | 353 | 105 |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | -810 | - | - | - |
| ROE (net income / shareholders' equity) | - | - | -13% | 5.77% | 14.1% |
| ROA (Net income/ Total Assets) | - | -12.5% | -6.18% | -0.05% | 3.52% |
| Assets 1 | - | 13,557 | 4,740 | 152,793 | 2,018 |
| Book Value Per Share 2 | - | 3.150 | 2.850 | 2.690 | 2.980 |
| Cash Flow per Share 2 | - | - | -0.4400 | -0.0200 | 0.1700 |
| Capex 1 | - | 167 | 113 | 153 | 169 |
| Capex / Sales | - | 5.6% | 2.82% | 3.21% | 2.89% |
| Announcement Date | 6/23/22 | 3/22/23 | 3/21/24 | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
3.172
CNY
Average target price
6.328
CNY
Spread / Average Target
+99.51%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -49.93% | 258M | |
| -4.84% | 182B | |
| +0.56% | 110B | |
| -3.35% | 68.11B | |
| +2.39% | 50.53B | |
| +9.36% | 44.8B | |
| +2.70% | 40.7B | |
| +3.43% | 26.53B | |
| +13.67% | 25.02B | |
| -0.32% | 24.96B |
- Stock Market
- Equities
- 9955 Stock
- Financials ClouDr Group Limited